Endo gets U.S. rights to Bioniche's Urocidin

Bioniche Life Sciences Inc. (TSX:BNC) granted Endo Pharmaceuticals Inc. (NASDAQ:ENDP) exclusive U.S. rights to Urocidin, a mycobacterial cell wall-DNA complex that is in a Phase III trial to treat ref...